Included in the reauthorization bill for the Food & Drug Admin-istration user fee program signed into law September 27 is a provision that requires additional administrative steps in tackling the sensitive issue of federal regulation of genetic testing.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

October 22, 2007 - Table of Contents

NIR October 22, 2007 (full PDF issue)

It’s Make or Break Time to Stop Medicare Lab Bidding Demo

Congress Says ‘Go Slow’ on Genetic Test Oversight

For Lab, Pathology Priorities on Capitol Hill, It’s Down to the Wire Again This Year

Medicare Lab Fee Schedule Preview

Diagnosis Coding News

Most Hospitals Get Full Pay Hike for Reporting Quality Data